SaeR as a novel target for antivirulence therapy against <i>Staphylococcus aureus</i>-Reference-Cited by-同舟云学术

SaeR as a novel target for antivirulence therapy against Staphylococcus aureus

Published:2023-09-10 Issue:2 Volume:12 Page:
ISSN:2222-1751
Container-title:Emerging Microbes & Infections
language:en
Short-container-title:Emerging Microbes & Infections

Author:

Gao Peng¹^ORCID,Wei Yuanxin¹,Hou Suying¹,Lai Pok-Man¹,Liu Han²^ORCID,Tai Sherlock Shing Chiu¹,Tang Victor Yat Man¹,Prakash Pradeep Halebeedu¹^ORCID,Sze Kong-Hung¹^ORCID,Chen Jonathan Hon Kwan¹^ORCID,Sun Hongzhe²^ORCID,Li Xuechen²^ORCID,Kao Richard Yi-Tsun¹^ORCID

Affiliation:

1. Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, China

2. Morningside Laboratory for Chemical Biology and Department of Chemistry, The University of Hong Kong, Hong Kong, People’s Republic of China

Funder

Health and Medical Research Fund

HMRF Project

Research Grants Council, University Grants Committee

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Drug Discovery,General Medicine,Immunology,Microbiology,Parasitology,Epidemiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/22221751.2023.2254415

Reference47 articles.